Impact of Serum Adiponectin Level on Insulin and hs-CRP in Patients with Type 2 Diabetes: A Case-Control Study
PDF

Keywords

Adiponectin
Insulin
hs-CRP
Type 2 Diabetes Mellitus (T2D)
HOMA-IR
Fasting Serum Glucose
Overweight

Categories

How to Cite

1.
Jawad H, Ali S, Jawad M. Impact of Serum Adiponectin Level on Insulin and hs-CRP in Patients with Type 2 Diabetes: A Case-Control Study. ASIDE Int Med. 2025;1(2):20-23. doi:10.71079/ASIDE.IM.03182550

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is marked by insulin resistance, hyperglycemia, and systemic inflammation. Adiponectin—a hormone produced mainly by adipose tissue—enhances insulin sensitivity and exhibits anti‐inflammatory properties. This study evaluated serum adiponectin and related metabolic markers in Iraqi patients with T2DM versus healthy controls.

Methods: In a case-control design, 84 Iraqi subjects were recruited (45 patients with T2DM and 39 controls). Fasting blood samples were obtained to measure adiponectin, insulin, high-sensitivity C-reactive protein (hs-CRP), fasting serum glucose (FSG), and Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) using standardized ELISA and biochemical assays. Correlations between adiponectin and anthropometric parameters were also analyzed.

Results: Controls showed significantly higher serum adiponectin and insulin levels (p < 0.05) compared to patients with T2DM. In contrast, hs-CRP, FSG, and HOMA-IR were significantly elevated in the diabetic group (p < 0.05). Moreover, adiponectin demonstrated significant negative correlations with both height and weight among controls, with their lower body weight suggesting enhanced fatty acid oxidation.

Conclusions: These findings indicate that elevated adiponectin is associated with improved insulin sensitivity and reduced inflammatory markers. The data support the potential role of adiponectin in mitigating insulin resistance, hyperglycemia, and overweight risks in T2DM, warranting further investigation into its therapeutic utility.

PDF

References

1. Migdalis IN. Chronic Complications of Diabetes: Prevalence, Prevention, and Management. J Clin Med. 2024: [PMID: 39685460 https://doi.org/10.3390/jcm13237001]

2. Seiglie JA, Marcus ME, Ebert C, Prodromidis N, Geldsetzer P, Theilmann M, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, Bovet P, Brian G, Dorobantu M, Gathecha G, Gurung MS, Guwatudde D, Msaidie M, Houehanou C, Houinato D, Jorgensen JMA, Kagaruki GB, Karki KB, Labadarios D, Martins JS, Mayige MT, Wong-McClure R, Mwangi JK, Mwalim O, Norov B, Quesnel-Crooks S, Silver BK, Sturua L, Tsabedze L, Wesseh CS, Stokes A, Atun R, Davies JI, Vollmer S, Barnighausen TW, Jaacks LM, Meigs JB, Wexler DJ, Manne-Goehler J. Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries. Diabetes Care. 2020: 767 [PMID: 32051243 https://doi.org/10.2337/dc19-1782]

3. Matalqah SM, Al-Tawalbeh DM. Medicinal plants potential against diabetes mellitus. diabetes. 2025: 11

4. Wang Y, Yang S, Guan Q, Chen J, Zhang X, Zhang Y, Yuan Y, Su Z. Effects of Genetic Variants of Nuclear Receptor Y on the Risk of Type 2 Diabetes Mellitus. J Diabetes Res. 2019: 4902301 [PMID: 31205951 https://doi.org/10.1155/2019/4902301]

5. Faris Raheem M, H. Ali S, G. Shareef L. Impact of serum levels of vitamin D on lipid profiles, glycemic indices, and insulin resistance in obese type 2 diabetes patients: An observational study. F1000Research. 2022: https://doi.org/10.12688/f1000research.125191.1]

6. Namazi N, Moghaddam SS, Esmaeili S, Peimani M, Tehrani YS, Bandarian F, Shobeiri P, Nasli-Esfahani E, Malekpour MR, Rezaei N, Rezaei N, Arjmand B, Larijani B, Farzadfar F. Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease study 2019. BMC Public Health. 2024: 98 [PMID: 38183083 https://doi.org/10.1186/s12889-023-16540-8]

7. Pi D, Wang J, Zhao M, Liu M, Zhang Y, Qin C, Yang L, Yan X, Nie G. Adiponectin and adiponectin receptors in common carp (Cyprinus carpio): Tissue distribution and their expressions in response to high-carbohydrate and high-lipid diets. Aquaculture Reports. 2022: https://doi.org/10.1016/j.aqrep.2022.101341]

8. Polak-Szczybylo E, Tabarkiewicz J. The Influence of Body Composition, Lifestyle, and Dietary Components on Adiponectin and Resistin Levels and AR Index in Obese Individuals. Int J Mol Sci. 2025: [PMID: 39796247 https://doi.org/10.3390/ijms26010393]

9. Akhtar Y, Nawaz S, Khan MS, Habib SH, Malik MH, Fatima S. Relationship Of Serum Adiponectin Levels With Glycaemic Status In Pregnant Women. J Ayub Med Coll Abbottabad. 2022: 235 [PMID: 35576278 https://doi.org/10.55519/JAMC-02-9491]

10. Baldelli S, Aiello G, Mansilla Di Martino E, Campaci D, Muthanna FMS, Lombardo M. The Role of Adipose Tissue and Nutrition in the Regulation of Adiponectin. Nutrients. 2024: [PMID: 39125318 https://doi.org/10.3390/nu16152436]

11. Guo L, Jin K, Sun Q, Zhang C, Chen X, Geng Z. Adiponectin regulates proliferation and differentiation of chicken skeletal muscle satellite cells via ERK1/2 and p38 signaling pathways. Poult Sci. 2025: 104813 [PMID: 39823838 https://doi.org/10.1016/j.psj.2025.104813]

12. Chen T-W, Wang C-H, Kuo F-C, Lee MS, Lee G-B. A dual-aptamer sandwich assay by detection of C-reactive protein in synovial fluid on an integrated microfluidic system for diagnosis of periprosthetic joint infection. Sensors and Actuators B: Chemical. 2025: https://doi.org/10.1016/j.snb.2024.136932]

13. Romero-Ferreiro V, Garcia-Fernandez L, Biscaia JM, Romero C, Gonzalez-Soltero R, De la Fuente M, Alvarez-Mon MA, Wynn R, Rodriguez-Jimenez R. Effect of probiotics on C-reactive protein levels in schizophrenia: Evidence from a systematic review and meta-analysis. Complement Ther Med. 2025: 103126 [PMID: 39798817 https://doi.org/10.1016/j.ctim.2025.103126]

14. Biernacka-Bartnik A, Kocelak P, Owczarek AJ, Choreza PS, Markuszewski L, Madej P, Puzianowska-Kuznicka M, Chudek J, Olszanecka-Glinianowicz M. The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome. Front Med (Lausanne). 2023: 1100547 [PMID: 36968815 https://doi.org/10.3389/fmed.2023.1100547]

15. Wu M, Hao Y, Wu X, Zhu M, Chen X, Qi J, Yu Z, Xu H. SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy. Acta Biochim Biophys Sin (Shanghai). 2024: 586 [PMID: 38449390 https://doi.org/10.3724/abbs.2024002]

16. Asimakidou E, Saipuljumri EN, Lo CH, Zeng J. Role of metabolic dysfunction and inflammation along the liver–brain axis in animal models with obesity-induced neurodegeneration. Neural Regeneration Research. 2025: 1069 https://doi.org/10.4103/nrr.Nrr-d-23-01770]

17. El-Araby RE, Tu Q, Xie Y, Aboushousha T, Li Z, Xu X, Zhu ZX, Dong LQ, Chen J. Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes. Aging Dis. 2024: 1059 [PMID: 38916734 https://doi.org/10.14336/AD.2024.0162]

18. Faraj M. LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue. J Biomed Res. 2020: 251 [PMID: 32701068 https://doi.org/10.7555/JBR.34.20190124]

19. Nasteska D, Fine NHF, Ashford FB, Cuozzo F, Viloria K, Smith G, Dahir A, Dawson PWJ, Lai YC, Bastidas-Ponce A, Bakhti M, Rutter GA, Fiancette R, Nano R, Piemonti L, Lickert H, Zhou Q, Akerman I, Hodson DJ. PDX1(LOW) MAFA(LOW) beta-cells contribute to islet function and insulin release. Nat Commun. 2021: 674 [PMID: 33514698 https://doi.org/10.1038/s41467-020-20632-z]

20. Wu W, Chen G, Zhang X, Wu H, Wang YE, Li X, Liang Y, Liu D. The effect of long-term exposure to moderate high altitude on adipokines and insulin sensitivity. Cytokine. 2025: 156823 [PMID: 39626424 https://doi.org/10.1016/j.cyto.2024.156823]

21. Shimizu R, Suzuki H, Amitani M, Amitani H. The Effects of Yoga on Key Adipocytokines in Obesity: A Narrative Review of Leptin and Adiponectin. Cureus. 2025: e76792 [PMID: 39897330 https://doi.org/10.7759/cureus.76792]

22. Hafiane A. Adiponectin-mediated regulation of the adiponectin cascade in cardiovascular disease: Updates. Biochem Biophys Res Commun. 2024: 149406 [PMID: 38134479 https://doi.org/10.1016/j.bbrc.2023.149406]

23. Lara-Guzman OJ, Arango-Gonzalez AM, Alvarez-Quintero R, Escobar JS, Munoz-Durango K, Sierra JA. Circulating hs-CRP, IL-18, Chemerin, Leptin, and Adiponectin Levels Reflect Cardiometabolic Dysfunction in Adults with Excess Weight. Int J Mol Sci. 2025: [PMID: 39940942 https://doi.org/10.3390/ijms26031176]

24. Norton EM, Avila F, Schultz NE, Mickelson JR, Geor RJ, McCue ME. Evaluation of an HMGA2 variant for pleiotropic effects on height and metabolic traits in ponies. J Vet Intern Med. 2019: 942 [PMID: 30666754 https://doi.org/10.1111/jvim.15403]

25. Barnabe MA, Elliott J, Harris PA, Menzies-Gow NJ. Relationships between total adiponectin concentrations and obesity in native-breed ponies in England. Equine Vet J. 2024: 264 [PMID: 37800870 https://doi.org/10.1111/evj.14013]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 ASIDE Internal Medicine